| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Pharvaris N.V.'s insiders have reduced their positions by a net 559,502 shares worth roughly $20.4M.
Classified under Biotechnology (Healthcare sector), PHVS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 650.0K | $22.75M | - | |
| Dir | 115.2K | $4.17M | - | |
| CFO | 113.8K | - | - | |
| Pres | 110.0K | $3.42M | - | |
| Other | 74.0K | $2.83M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Souverijns Wim | Chief Commercial Officer | Sale+OE10b5-1 | 26,090 | $39.23 | $1,023,575.10 | -40.1% | - | - | |
| Sep 14, 2026 | Modig Berndt | Chief Executive Officer | Sell10b5-1 | 2,291 | $39.40 | $90,275.94 | -1.8% | - | - | |
| Sep 11, 2026 | Lu Peng | President | Sale+OE10b5-1 | 15,000 | $40.13 | $601,947.00 | -18.7% | - | - | |
| Sep 10, 2026 | Lesage Anne | Chief Early Development | Sale+OE10b5-1 | 30,000 | $38.30 | $1,149,084.00 | -34.7% | - | - | |
| Sep 9, 2026 | Glassman Robert | Director | Sale+OE10b5-1 | 8,000 | $37.55 | $300,396.00 | -43.2% | - | - | |
| Sep 8, 2026 | Lu Peng | President | Sale+OE10b5-1 | 15,000 | $40.68 | $610,134.00 | -18.7% | - | - | |
| Aug 14, 2026 | Modig Berndt | Chief Executive Officer | Sell10b5-1 | 2,292 | $34.77 | $79,685.73 | -1.7% | - | - | |
| Jul 13, 2026 | Modig Berndt | Chief Executive Officer | Sell10b5-1 | 2,292 | $34.97 | $80,154.45 | -1.7% | -11.9% | - | |
| Jun 30, 2026 | Schikan Johannes Gerardus Christiaan Petrus | Director | Sell10b5-1 | 37,600 | $35.41 | $1,331,495.86 | -10.7% | -7.7% | - | |
| Jun 30, 2026 | Lesage Anne | Chief Early Development | Sale+OE10b5-1 | 76,172 | $35.39 | $2,695,452.13 | -33.3% | -7.7% | - |